[go: up one dir, main page]

GB201813136D0 - Antibody for ovarian cancer treatment - Google Patents

Antibody for ovarian cancer treatment

Info

Publication number
GB201813136D0
GB201813136D0 GBGB1813136.7A GB201813136A GB201813136D0 GB 201813136 D0 GB201813136 D0 GB 201813136D0 GB 201813136 A GB201813136 A GB 201813136A GB 201813136 D0 GB201813136 D0 GB 201813136D0
Authority
GB
United Kingdom
Prior art keywords
antibody
ovarian cancer
cancer treatment
treatment
ovarian
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1813136.7A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medannex Ltd
Original Assignee
Medannex Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medannex Ltd filed Critical Medannex Ltd
Priority to GBGB1813136.7A priority Critical patent/GB201813136D0/en
Publication of GB201813136D0 publication Critical patent/GB201813136D0/en
Ceased legal-status Critical Current

Links

GBGB1813136.7A 2018-08-10 2018-08-10 Antibody for ovarian cancer treatment Ceased GB201813136D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GBGB1813136.7A GB201813136D0 (en) 2018-08-10 2018-08-10 Antibody for ovarian cancer treatment

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1813136.7A GB201813136D0 (en) 2018-08-10 2018-08-10 Antibody for ovarian cancer treatment

Publications (1)

Publication Number Publication Date
GB201813136D0 true GB201813136D0 (en) 2018-09-26

Family

ID=63667033

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1813136.7A Ceased GB201813136D0 (en) 2018-08-10 2018-08-10 Antibody for ovarian cancer treatment

Country Status (1)

Country Link
GB (1) GB201813136D0 (en)

Similar Documents

Publication Publication Date Title
IL308805B2 (en) Anti-pd-1 antibodies for treatment of lung cancer
IL264674B1 (en) Anti-siglec-7 antibodies for the treatment of cancer
IL277861A (en) Axl-specific antibodies for cancer treatment
IL267804A (en) Methods of treating cancer with anti-pd-1 antibodies
IL276303A (en) Methods for treating cancer with anti-pd-1 antibodies
IL253462A0 (en) Treatment of cancer with anti-lap monoclonal antibodies
IL274766A (en) Humanized anti-liv1 antibodies for the treatment of breast cancer
IL260444B (en) Anti-her2 combinations for cancer treatment
EP3645040A4 (en) Use of anti-fam19a5 antibodies for treating cancers
GB201709405D0 (en) Compounds for treating ovarian cancer
TWI560201B (en) Bi-specific antibodies for treating cancer
SG11202101397TA (en) Biomarkers for cancer therapy
EP3706770A4 (en) Immunotherapeutic combination for treating cancer
IL289842A (en) Humanized anti-liv1 antibodies for the treatment of cancer
IL268416A (en) Pharmaceutical combinations for treating cancer
EP3582805A4 (en) ANTI-PD-L1 ANTIBODY TREATMENT FOR BLADDER CANCER
SG11202010528XA (en) Combinations for treating cancer
GB201703907D0 (en) Novel therapies for cancer
IL280421A (en) Cancer treatment by antibody
IL265537A (en) Methods for treating ovarian cancer
GB2571036B (en) Aglycosylated antibody Fc region for treating cancer
GB201813136D0 (en) Antibody for ovarian cancer treatment
HK40046198A (en) Axl-specific antibodies for cancer treatment
GB201813138D0 (en) Cancer treatment with an antibody
HK40029718A (en) Humanized anti-liv1 antibodies for the treatment of breast cancer

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)